A few stocks from the ASX listed companies are following a higher growth trajectory. These stocks from potential growth companies are
Telix Pharmaceuticals Limited (ASX: TLX)
Telix Pharmaceuticals Limited (ASX: TLX) delivered a robust update for the quarter ending 30 September 2024 (Q3 2024), reporting unaudited revenue of approximately US$135 million (AU$201 million). This marks a 55% year-over-year growth (Q3 2023: US$87 million) and a 9% sequential increase from Q2 2024 (US$124 million). Year-to-date revenue stands at US$374 million (AU$565 million), driven predominantly by the strong performance of Illuccix, its prostate cancer imaging agent, in the U.S. market, which contributed US$131 million (AU$195 million) for the quarter. The company reaffirmed its FY2024 revenue guidance of US$490–510 million (AU$745–776 million), representing a substantial 48–54% growth over FY2023. Telix also maintained its expectation of a 40–50% increase in R&D expenditure for the year, with investments supported by robust earnings from product sales.
The quarter highlighted Telix’s execution of its growth strategy in the U.S., where its Precision Medicine (Px) business unit continued to drive adoption of PSMA imaging solutions, consolidating its leadership in the urology segment. This performance was bolstered by its strategic sales and marketing initiatives to enhance market share and deepen its penetration within the imaging and treatment ecosystem for urological cancers. In a significant financial milestone, the company secured AU$650 million through a convertible bond offering, with strong backing from investors. These funds will enable Telix to accelerate its clinical pipeline, pursue strategic M&A opportunities, and enhance its global supply chain and manufacturing infrastructure. One notable investment includes the US$230 million acquisition of RLS (USA) Inc, strengthening Telix’s North American manufacturing capabilities as part of its operational expansion strategy.
Looking ahead, Telix appears to be the best growth stocks to buy now, well-positioned to leverage its strong cash reserves and earnings to advance its pipeline of late-stage therapeutic assets, commercialize three new imaging agents, and continue infrastructure investments. The company’s performance underscores its growing prominence in the radiopharmaceutical sector, with a clear focus on delivering long-term value creation through innovation and operational execution.
Black Cat Syndicate (ASX: BC8)
Black Cat Syndicate (ASX: BC8) is among the growing companies to invest in, focused on becoming a dominant player in three key gold districts: the Paulsens Gold Operation in the Pilbara, Kal East Gold Operation east of Kalgoorlie, and the Coyote Gold Operation in the West Tanami. With mining underway at Paulsens and Kal East, and processing having commenced at Kal East and soon at Paulsens, the company is well on its way to meeting its goals. Notably, the first gold pour from the Myhree open pit at Kal East, discovered by Black Cat in 2018, marks a significant milestone for the company. The Paulsens operation is progressing as planned, with the refurbishment of its processing facility and high-grade stockpile strategy on track for commissioning by December 2024. The company is benefiting from a rising gold price, which has boosted its financial position, making it well-positioned to expand production and further capitalise on its assets.
Black Cat's growth strategy is to ramp up production, targeting 100,000 ounces per year by the end of 2025 from Paulsens and Kal East. Additionally, the company aims for longer-term growth, with plans to expand production to over 200,000 ounces per year post-2025. The company is fully funded, debt-free, and unhedged, which provides financial stability to accelerate growth. At Kal East, the company plans to expand processing capacity and mine throughput, while also fast-tracking exploration to extend mine life and resource growth. In the short term, Black Cat is focused on optimising production, converting resources into reserves, and growing its near-mine resources.
The Paulsens operation is set for commissioning in December 2024, with mining progressing safely and efficiently. The plant refurbishment is on track, and high-grade mining has begun on selective panels. In addition, the company is exploring the potential of antimony, a critical mineral, at the nearby Mt Clement project. With significant exploration upside at all of its assets, Black Cat is well-positioned to grow its resources and reserves. The company’s ongoing drilling and exploration efforts are aimed at growing its resource base and securing long-term production growth, ensuring it remains a leader in Australia’s gold sector.
Source: Company’s Report
Veye Pty Ltd(ABN 58 623 120 865), holds (AFSL No. 523157 ). All information provided by Veye Pty Ltd through its website, reports, and newsletters is general financial product advice only and should not be considered a personal recommendation to buy or sell any asset or security. Before acting on the advice, you should consider whether it’s appropriate to you, in light of your objectives, financial situation, or needs. You should look at the Product Disclosure Statement or other offer document associated with the security or product before making a decision on acquiring the security or product. You can refer to our Terms & Conditions and Financial Services Guide for more information. Any recommendation contained herein may not be suitable for all investors as it does not take into account your personal financial needs or investment objectives. Although Veye takes the utmost care to ensure accuracy of the content and that the information is gathered and processed from reliable resources, we strongly recommend that you seek professional advice from your financial advisor or stockbroker before making any investment decision based on any of our recommendations. All the information we share represents our views on the date of publishing as stocks are subject to real time changes and therefore may change without notice. Please remember that investments can go up and down and past performance is not necessarily indicative of future returns. We request our readers not to interpret our reports as direct recommendations. To the extent permitted by law, Veye Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss, or data corruption) (as mentioned on the website www.veye.com.au), and confirms that the employees and/or associates of Veye Pty Ltd do not hold positions in any of the financial products covered on the website on the date of publishing this report. Veye Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services.